Inicio › Lupus › Florida

Ensayos clínicos de Lupus en Florida

23 estudios sobre Lupus buscan participantes en Florida.

Ciudades en Florida

Texto oficial del estudio (inglés)

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Research Site, Brandon
Research Site, Miami
Research Site, Miami
y 1 más

ReclutandoFase 3

Edades de 18 a 70 · Todos los sexos · Actualizado el 13 nov 2026 · NCT07430306

A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)

AARDS Research, Inc., Aventura
Meris Clinical Research-Brandon-69466, Brandon
Clinical Research of West Florida, Inc., Clearwater
y 2 más

ReclutandoFase 2

Edades de 18 a 74 · Todos los sexos · Actualizado el 12 nov 2026 · NCT07409181

Study of Afimetoran in Adults With Cutaneous Lupus Erythematosus

Omega Research DeBary, LLC, DeBary

ReclutandoFase 2/3

Edades de 16 en adelante · Todos los sexos · Actualizado el 10 nov 2026 · NCT07881120

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Clinical Res Of W Florida, Clearwater
GNP Research, Cooper City
Homestead Assoc In Research Inc, Homestead
y 2 más

ReclutandoFase 3

Edades de 12 a 100 · Todos los sexos · Actualizado el 9 nov 2026 · NCT06133972

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)

Omega Research Debary, LLC, DeBary
Centre for Rheumatology, Immunology and Arthritis, Fort Lauderdale
South Florida Rheumatology, Hollywood
y 3 más

ReclutandoFase 3

Edades de 18 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07355218

A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

GNP Research at Mark Jaffe, MD, Cooper City
Advance Medical Research Center, Miami
Diverse Clinical Research LLC, Miami
y 2 más

ReclutandoFase 3

Edades de 18 a 75 · Todos los sexos · Actualizado el 4 nov 2026 · NCT07332481

A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus

Arthritis & Rheumatic Disease Specialties, Aventura
Clinical Research of West Florida 1, Clearwater
Avanti Clinical Research Corp, Hialeah
y 4 más

ReclutandoFase 3

Edades de 18 a 75 · Todos los sexos · Actualizado el 3 nov 2026 · NCT07438496

A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants

Centre for Rheumatology, Immunology and Arthritis, Fort Lauderdale
South Florida Rheumatology, Hollywood
LIFE Clinical Trials, Margate
y 1 más

ReclutandoEstudio observacional

Edades de 16 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT07175285

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

Mayo Clinic, Jacksonville

ReclutandoFase 1

Edades de 18 a 74 · Todos los sexos · Actualizado el 2 nov 2026 · NCT07085104

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

Sl0044 50239, Brandon
Sl0044 50630, Clearwater
Sl0044 50751, Coral Gables
y 9 más

ReclutandoFase 3

Edades de 16 en adelante · Todos los sexos · Actualizado el 2 nov 2026 · NCT06617325

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

Research Site, Plantation

ReclutandoFase 1

Edades de 18 a 65 · Todos los sexos · Actualizado el 28 oct 2026 · NCT07201558

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

University of Florida, Gainesville

ReclutandoFase 1

Edades de 18 a 60 · Todos los sexos · Actualizado el 27 oct 2026 · NCT06975787

A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus

Omega Research Group, Orlando

ReclutandoFase 1

Edades de 18 a 70 · Todos los sexos · Actualizado el 26 oct 2026 · NCT06613360

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

Clinical Research Of West Florida - Phase I Unit /ID# 279292, Clearwater
Finlay Medical Research - Greenacres /ID# 278380, Greenacres City
Clinical Research of Osceola /ID# 278374, Kissimmee
y 3 más

ReclutandoFase 1

Edades de 18 a 75 · Todos los sexos · Actualizado el 20 oct 2026 · NCT07607964

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

Mayo Clinic, Jacksonville

ReclutandoFase 1/2

Edades de 12 a 65 · Todos los sexos · Actualizado el 6 oct 2026 · NCT06121297

A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases

Bioresearch Partner Coral Terrace, South Miami

ReclutandoFase 2

Edades de 18 a 75 · Todos los sexos · Actualizado el 5 oct 2026 · NCT06570798

A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis

GNP Research, Cooper City
University of Florida Clinical Research Center, Gainesville
Miami Dermatology and Laser Research, Miami
y 1 más

ReclutandoFase 2

Edades de 12 a 70 · Todos los sexos · Actualizado el 14 sept 2026 · NCT07570862

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE), Sjogren's Disease (SjD) and Rheumatoid Arthritis (RA)

Highlands Advanced Rheumatology And Arthritis Center - Avon Park /ID# 278239, Avon Park
Clinical Research Of West Florida - Phase I Unit /ID# 275834, Clearwater
Life Clinical Trials - Colonial Drive - Margate /ID# 276050, Margate
y 1 más

ReclutandoFase 1

Edades de 18 a 75 · Todos los sexos · Actualizado el 10 ago 2026 · NCT06977724

A Research Trial to Assess if Cenerimod is Efficacious and Safe to Treat Active Lupus Nephritis on Top of Regular Treatment

Dolphin Medical Research, Doral
Alloy Clinical Research LLC, Kissimmee
SouthCoast Research Center, Miami
y 4 más

ReclutandoFase 3

Edades de 18 a 75 · Todos los sexos · Actualizado el 30 jul 2026 · NCT07201129

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

US03-0, Clearwater
US05-0, Orlando

ReclutandoFase 1/2Se aceptan voluntarios sanos

Edades de 18 a 70 · Todos los sexos · Actualizado el 2 jun 2026 · NCT06625671

A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease

University of Florida, Gainesville
Nicklaus Children's Hospital, Miami

ReclutandoFase 1

Edades de 12 a 70 · Todos los sexos · Actualizado el 22 may 2026 · NCT06308978

Lupus Landmark Study: A Prospective Registry and Biorepository

University of Miami, Miami

ReclutandoEstudio observacional

Edades de 18 a 110 · Todos los sexos · Actualizado el 15 abr 2026 · NCT05934149

Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases.

IRIS Research and Development, LLC, Plantation

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 3 sept 2024 · NCT06581562

De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.